March 1, 2021
Business News

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation (IMVT) on Behalf of Investors


LOS ANGELES–()–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation (“HSAC”, “Immunovant”, or the “Company”) (NASDAQ: IMVT) investors concerning the Company’s possible violations of the federal securities laws.

If you suffered a loss on your Immunovant investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit your contact information at https://www.glancylaw.com/cases/immunovant-inc/. You can also contact Charles H. Linehan, of GPM at 310-201-9150,…



Click here to view the original article.

Related Posts

You might also like ...

Bluegreen Vacations Holding Corporation Reports Simpler, “Pure” Holding Company Structure and Financials
FinTech Collateral Velocity Closes Investment Round
Installed Building Products Announces the Acquisition of I.W. International Insulation, Inc. DBA Intermountain West Insulation